ATM and breast carcinoma: Regardless of these discrepancies, caspase-2 has been assigned tumor suppressor potential in animal models of MMTV/c-neu–driven breast cancer, ataxia-telangiectasia mutated (ATM) loss, and MYC-driven lymphomagenesis (19–21).